ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF THE DIFFERENTIATING AGENT N-METHYLFORMAMIDE IN MURINE TUMOR SYSTEMS

被引：22

作者：

IWAKAWA, M ^{[1
]}

TOFILON, PJ ^{[1
]}

HUNTER, N ^{[1
]}

STEPHENS, LC ^{[1
]}

MILAS, L ^{[1
]}

机构：

[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT VET MED & SURG,HOUSTON,TX 77030

来源：

CLINICAL & EXPERIMENTAL METASTASIS | 1987年 / 5卷 / 04期

关键词：

D O I：

10.1007/BF00120724

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：289 / 300

页数：12

共 15 条

[1] TERMINAL DIFFERENTIATION OF HUMAN PROMYELOCYTIC LEUKEMIA-CELLS INDUCED BY DIMETHYL-SULFOXIDE AND OTHER POLAR COMPOUNDS [J].

COLLINS, SJ ;

RUSCETTI, FW ;

GALLAGHER, RE ;

GALLO, RC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (05) :2458-2462

[2]

DEXTER DL, 1984, CANCER RES, V44, P4942

[3]

DEXTER DL, 1982, CANCER RES, V42, P5018

[4]

GESCHER A, 1982, BRIT J CANCER, V45, P843, DOI 10.1038/bjc.1982.136

[5]

HARPUR ES, 1986, CANCER CHEMOTH PHARM, V16, P139

[6]

IWAKAWA M, 1987, IN PRESS INT J RAD O

[7] N-METHYLFORMAMIDE (NSC 3051) - A POTENTIAL CANDIDATE FOR COMBINATION CHEMOTHERAPY [J].

LANGDON, SP ;

HICKMAN, JA ;

GESCHER, A ;

STEVENS, MFG ;

CHUBB, D ;

VICKERS, LM .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (06) :745-752

[8] THE CHEMOSENSITIVITY OF A NEW EXPERIMENTAL-MODEL - THE M5076 RETICULUM-CELL SARCOMA [J].

LANGDON, SP ;

GESCHER, A ;

HICKMAN, JA ;

STEVENS, MFG .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (05) :699-705

[9]

MILAS L, 1975, J NATL CANCER I, V54, P895

[10]

MILAS L, 1974, CANCER RES, V34, P61

← 1 2 →